Fructose: Clinical Trials

69 trials of Fructose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

48 completed, 9 unknown, 6 recruiting, 3 active not recruiting. 55 Not applicable, 3 Phase 2, 3 Phase 4, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable55Completed 41, Recruiting 6, Unknown 4, Active not recruiting 2, Not yet recruiting 1, Terminated 1
Phase 23Active not recruiting 1, Completed 1, Terminated 1
Phase 43Completed 3
Early Phase 11Unknown 1
Phase 11Completed 1
Phase 31Completed 1

Follow Fructose: new trials by email Literature Review of Fructose trials Research Report on Fructose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fructose for Acute Ischemic Stroke
10% Fructose Injection - Acute Ischemic Stroke
Phase 2Active not recruitingJi Xunming,MD,PhD462026-06-052026-06-18
Fructose and (Aging)
Fructose, Glucose - Intestinal Permeability, Immune Response
Not applicableRecruitingUniversity of Vienna322026-04-012026-08-11
Effects of Dual-Source Carbohydrate Intake and Liver Glycogen Repletion After Overnight Fasting.
No breakfast, Breakfast (0% Fructose), Breakfast (50% fructose) - Carbohydrate Metabolism, Hepatic Glycogen Storage
Not applicableNot yet recruitingManchester Metropolitan University122026-03-012026-03-17
Glucose-fructose Ratio Pilot
Glucose and fructose (one-to-one), Glucose and fructose (two-to-one) - Exercise Metabolism
Not applicableCompletedUniversity of Bath112026-01-142026-10-26
Effect of Low Dose Galactose on Glycaemia and Glucose Kinetics
galactose, fructose, Glucose Powder - Glucose
Not applicableRecruitingUniversity of Bath252026-01-012026-07-08
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
fructose, glucose - MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis
Not applicableRecruitingQueen Mary University of London722025-06-302026-07-31
Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I
Fructose, Fructose and galactose - Glycogen Storage Disease Type I
Not applicableRecruitingInsel Gruppe AG, University Hospital Bern202025-04-242026-05-12
Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose
Sucrose, Glucose, Fructose - Gastrointestinal Hormones, Glycemic Control
Not applicableActive not recruitingUniversity Hospital, Basel, Switzerland202025-02-062026-09-03
Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS
(R)-3-hydroxybutyl (R)-3-hydroxybutyrate), Maltodextrin, Fructose, Pectin, Sodium alginate, Sodium chloride - Schizophrenia and Related Disorders, Psychosis
Not applicableCompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)282024-12-012026-04-27
High Fructose Diet, the Gut Microbiome, and Metabolic Health
Fructose, glucose - MASLD, Type 2 Diabetes
Not applicableRecruitingIcahn School of Medicine at Mount Sinai302024-10-082025-12-17
The Role of Sugars in Fat Accumulation in the Liver
150g of fat with glucose, 150g of fat with fructose, 150g of fat with sucrose - Fatty Liver Disease
Not applicableRecruitingInstitute for Clinical and Experimental Medicine402024-06-202024-12-30
Exogenous Ketosis During Bed Rest in Older Adults
ketone monoester (R)-3-hydroxybutyl (R)-3- hydroxybutyrate, carbohydrate-fat placebo (fructose, corn and canola oil 50:50 ratio) - Muscle Protein Synthesis, Muscle Atrophy
Not applicableCompletedMcGill University302023-02-272024-02-07
BaRiatric Surgery AnD FRUctose Handeling In Obese subjecTs
fructose - Insulin Resistance
Not applicableUnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)202023-02-052023-02-08
Effect of Postoperative Oral Carbohydrate Administration in Total Knee Arthroplasty Elderly Patients
100ml carbohydrate containing 12.5g maltodextrin, fructose and glucose, Routine feeding - Total Knee Arthroplasty, Postoperative Oral Carbohydrates
Early Phase 1UnknownNanjing First Hospital, Nanjing Medical University642022-11-222023-05-01
A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors
Cohort 1: HFCS (fructose) fed, Cohort 2: D-Xylose (xylose-fed) - Colorectal Tumors
Not applicableCompletedWeill Medical College of Cornell University122022-02-162024-11-06
Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents
Erythritol, Sucrose, Glucose - Insulin Resistance, Glucose Tolerance
Not applicableActive not recruitingUniversity Hospital, Basel, Switzerland302021-08-182026-09-30
Effects of Rehydration During Physical Exercise on Acute Kidney Injury Biomarkers
Fructose/glucose/xylitol/saccharose - Acute Kidney Injury
Not applicableUnknownMedical University of Gdansk302020-03-092020-03-17
Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin Degludec
Fructose, Plain water - Type 1 Diabetes Mellitus, Diabetes Complications
Not applicableCompletedInsel Gruppe AG, University Hospital Bern152019-01-042019-09-20
Vascular and Metabolic Consequences of Adopting a Westernized Lifestyle
Fructose and physical inactivity - Vascular Diseases
Not applicableCompletedUniversity of Missouri-Columbia522018-11-302022-08-17
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Fructose-containing Sugars - Body Weight, Obesity
UnknownJohn Sievenpiper12018-09-042019-01-15

Showing 20 of 69. Sign in to see all of them.

Conditions studied

Insulin Resistance (9)  ·  Diabetes Mellitus (6)  ·  Diabetes Mellitus, Type 2 (5)  ·  Dyslipidemias (5)  ·  Metabolic Syndrome (5)  ·  Non-alcoholic Fatty Liver Disease (5)  ·  Obesity (5)  ·  Cardiovascular Diseases (4)  ·  Overweight (4)  ·  Body Weight (3)  ·  Exploratory Behavior (3)  ·  Fatty Liver (3)  ·  Hypertriglyceridemia (3)  ·  Pain (3)  ·  Sedentary Behavior (3)

Sponsors

University Hospital, Basel, Switzerland (5)  ·  University of Toronto (4)  ·  University of Lausanne (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Federal University of Rio Grande do Sul (2)  ·  Insel Gruppe AG, University Hospital Bern (2)  ·  Institute for Clinical and Experimental Medicine (2)  ·  Rockefeller University (2)  ·  The Rogosin Institute (2)  ·  Unilever R&D (2)  ·  Universitaire Ziekenhuizen KU Leuven (2)  ·  University of Bath (2)  ·  University of California, Davis (2)  ·  University of Nottingham (2)  ·  Albert Einstein College of Medicine (1)

Countries

United States (12)  ·  Switzerland (11)  ·  Canada (9)  ·  United Kingdom (7)  ·  Netherlands (5)  ·  Austria (3)  ·  China (3)  ·  Brazil (2)  ·  Czechia (2)  ·  Italy (2)  ·  Sweden (2)  ·  Denmark (1)  ·  Finland (1)  ·  New Zealand (1)  ·  Poland (1)

Top investigators

Christoph Beglinger, MD (2)  ·  Kimber L Stanhope, Ph.D, R.D. (2)  ·  Lisa Hudgins, MD (2)  ·  Luc Tappy, MD (2)  ·  Anne Christin Meyer-Gerspach, PD, PhD (1)  ·  Camila Manrique Acevedo, MD (1)  ·  Christoph Beglinger, Prof (1)  ·  Christoph Stettler, MD (1)  ·  David Green (1)  ·  Dita Pajuelo, PhD (1)  ·  Duo Li, Doctor (1)  ·  Giles AD Major, BM BCh MA MRCP (1)

Results publications

PMID 21252253, PMID 21613559, PMID 21677052, PMID 21956423, PMID 22522612, PMID 22933433, PMID 23034968, PMID 25879513, PMID 25904601, PMID 26537945, PMID 26674497, PMID 26702120, PMID 27746233, PMID 28100512, PMID 28350714, PMID 28860128, PMID 29722834, PMID 29806553, PMID 29890724, PMID 30463844, PMID 30844053, PMID 31061018, PMID 31136656, PMID 31288630, PMID 31365624, PMID 31796953, PMID 31826724, PMID 32558624, PMID 32591421, PMID 32875733, PMID 32916151, PMID 33381794, PMID 34087940, PMID 34265055, PMID 36040803, PMID 36184254, PMID 36235639, PMID 36338481, PMID 36842451, PMID 37582096, PMID 38969065, PMID 40414296, PMID 40568354, PMID 40721209, PMID 42833446

NIH funding

R01DK079974 (1), R01DK137968 (1), R01HL075675 (1), R01HL091333 (1), R01HL107256 (1)